These limitations notwithstanding, there has been significant recent interest in the roles that KDM6A may play in CKD and in the possibility of therapeutically targeting histone modifying enzymes to alter the natural history of kidney disease (Fontecha-Barriuso et al., 2018). The gene discussed is KDM6A; the disease is chronic kidney disease.